Clinical Trials Directory

Trials / Completed

CompletedNCT00777556

Emergency Contraception Actual Use Study

Plan B® 1.5 Emergency Contraception Actual Use Study in Adolescents

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
343 (actual)
Sponsor
Duramed Research · Industry
Sex
Female
Age
11 Years – 16 Years
Healthy volunteers
Accepted

Summary

This is a non-comparative case series study to assess the ability of females 11-16 years of age, inclusive, who are requesting emergency contraception (EC) to use the study product, DR-104 (Plan B® 1.5), appropriately and safely without provider counseling.

Detailed description

To simulate an over-the-counter (OTC) setting, each potential subject was expected to read the label text on the outside of the study package and determine whether and how to use the study product without provider direction or assistance. The study product, Plan B® 1.5, was to be dispensed only to those subjects who appropriately self-selected and indicated that they wanted to participate in the study and receive study product. Subjects could also appropriately self-select not to use the study product. Follow-up contact was to be conducted at approximately one, four, and eight weeks following the date the subject was dispensed study product. At these contacts, subjects answered questions regarding product use, health problems since last contact, and pregnancy status. Subjects were not to be permitted to enroll more than once in this Actual Use Study, however to assess repeat use of emergency contraceptives (EC) (use in addition to the study product) subjects were also queried at the one-, four-, and eight-week follow-up contacts regarding use of additional EC.

Conditions

Interventions

TypeNameDescription
DRUGDR-104One 1.5 mg tablet of levonorgestrel for emergency contraception within 72 hours following unprotected sexual intercourse.

Timeline

Start date
2008-10-01
Primary completion
2010-12-01
Completion
2010-12-01
First posted
2008-10-22
Last updated
2012-10-18
Results posted
2012-10-18

Locations

5 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00777556. Inclusion in this directory is not an endorsement.